SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-029320
Filing Date
2019-08-06
Accepted
2019-08-06 16:01:43
Documents
12
Period of Report
2019-08-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K flxn-8k_20190802.htm 8-K 44009
2 EX-99.1 flxn-ex991_6.htm EX-99.1 114669
3 EX-99.2 flxn-ex992_8.htm EX-99.2 4117
4 EX-99.3 exhibit99_3.htm EX-99.3 524784
5 GRAPHIC gukgwjibhwju000002.jpg GRAPHIC 251793
6 GRAPHIC gukgwjibhwju000003.jpg GRAPHIC 154427
7 GRAPHIC gukgwjibhwju000006.jpg GRAPHIC 186930
8 GRAPHIC gukgwjibhwju000004.jpg GRAPHIC 188964
9 GRAPHIC gfqla4brpxzz000001.jpg GRAPHIC 126974
10 GRAPHIC gukgwjibhwju000001.jpg GRAPHIC 159001
11 GRAPHIC gukgwjibhwju000005.jpg GRAPHIC 193166
12 GRAPHIC gukgwjibhwju000007.jpg GRAPHIC 129077
  Complete submission text file 0001564590-19-029320.txt   2604215
Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803
Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777
Flexion Therapeutics Inc (Filer) CIK: 0001419600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36287 | Film No.: 191001938
SIC: 2834 Pharmaceutical Preparations